the potential use of car-t therapy following autologous transplantation in multiple myeloma
Published 1 year ago • 121 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
3:03
the future of car-t therapy for multiple myeloma
-
4:04
overcoming challenges in car t-cell therapy for multiple myeloma
-
4:14
challenges with the real-world use of car-t therapy in multiple myeloma
-
1:38
real world use of car t-cell therapy in multiple myeloma
-
3:06
management of multiple myeloma during car-t therapy manufacturing
-
4:04
the future of myeloma treatment and the possibility of cure
-
6:18
what to expect with car t cell therapy and bispecifics in myeloma (2022) | dr. joshua richter
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
1:12
optimizing car-t therapy for patients with multiple myeloma in the real-world
-
9:58
the management & optimization of car t-cell therapy in myeloma
-
4:29
car-t therapy vs. asct for myeloma
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
4:12
car-t therapy in multiple myeloma: recent updates, clinical trials and future outlooks
-
2:00
the value of car-t cell therapy for the treatment of r/r multiple myeloma
-
2:35
latest advances in car-t for multiple myeloma: cilta-cel & new car-t platforms
-
9:48
the use of car t-cells in multiple myeloma
-
0:57
focusing on allogeneic car t-cell therapies for myeloma
-
2:40
car t-cell therapy to revolutionize multiple myeloma?
-
3:27
car-t cells in myeloma
-
2:40
huge potential for car-t therapy in myeloma
-
2:37
car-t in myeloma: what is the potential?
-
1:45
car t-cells in myeloma: patients’ perspective